Triazolam
Generic name: Pronounced as (trye ay' zoe lam)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 05/15/2021
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
Triazolam may increase the risk of serious or life-threatening breathing problems, sedation, or coma if used along with certain medications. Tell your doctor if you are taking or plan to take certain opiate medications for cough such as codeine (in Triacin-C, in Tuzistra XR) or hydrocodone (in Anexsia, in Norco, in Zyfrel) or for pain such as codeine (in Fiorinal), fentanyl (Actiq, Duragesic, Subsys, others), hydromorphone (Dilaudid, Exalgo), meperidine (Demerol), methadone (Dolophine, Methadose), morphine (Astramorph, Duramorph PF, Kadian), oxycodone (in Oxycet, in Percocet, in Roxicet, others), and tramadol (Conzip, Ultram, in Ultracet). Your doctor may need to change the dosages of your medications and will monitor you carefully. If you take triazolam with any of these medications and you develop any of the following symptoms, call your doctor immediately or seek emergency medical care immediately: unusual dizziness, lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness. Be sure that your caregiver or family members know which symptoms may be serious so they can call the doctor or emergency medical care if you are unable to seek treatment on your own.
Triazolam may be habit forming. Do not take a larger dose, take it more often, or for a longer time than your doctor tells you to. Tell your doctor if you have ever drunk large amounts of alcohol, if you use or have ever used street drugs, or have overused prescription medications. Do not drink alcohol or use street drugs during your treatment. Drinking alcohol or using street drugs during your treatment with triazolam also increases the risk that you will experience these serious, life-threatening side effects. Also tell your doctor if you have or have ever had depression or another mental illness.
Triazolam may cause a physical dependence (a condition in which unpleasant physical symptoms occur if a medication is suddenly stopped or taken in smaller doses), especially if you take it for several days to several weeks. Do not stop taking this medication or take fewer doses without talking to your doctor. Stopping triazolam suddenly can worsen your condition and cause withdrawal symptoms that may last for several weeks to more than 12 months. Your doctor probably will decrease your triazolam dose gradually. Call your doctor or get emergency medical treatment if you experience any of the following symptoms: unusual movements; ringing in your ears; anxiety; memory problems; difficulty concentrating; sleep problems; seizures; shaking; muscle twitching; changes in mental health; depression; burning or prickling feeling in hands, arms, legs or feet; seeing or hearing things that others do not see or hear; thoughts of harming or killing yourself or others; overexcitement; or losing touch with reality.
Why is this medication prescribed?
Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
How should this medicine be used?
Triazolam comes as a tablet to take by mouth. It is usually taken as needed at bedtime but not with or shortly after a meal. Triazolam may not work well if it is taken with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take triazolam exactly as directed.
You will probably become very sleepy soon after you take triazolam and will remain sleepy for some time after you take the medication. Plan to go to bed right after you take triazolam and to stay in bed for 7 to 8 hours. Do not take triazolam if you will be unable to remain asleep for 7 to 8 hours after taking the medication. If you get up too soon after taking triazolam, you may experience memory problems.
Your sleep problems should improve within 7 to 10 days after you start taking triazolam. Call your doctor if your sleep problems do not improve during this time, if they get worse at any time during your treatment, or if you notice any changes in your thoughts or behavior.
Triazolam should normally be taken for short periods of time (usually 7 to 10 days). You should not take triazolam for more than 2 to 3 weeks without talking to your doctor. If you take triazolam for 7 to 10 days or longer, triazolam may not help you sleep as well as it did when you first began to take the medication, and you may wake up more easily during the last third of the night. You may also start to feel anxious or nervous during the day, and you may develop dependence ('addiction'; a need to continue taking the medication) on triazolam. Talk to your doctor about the risks of taking triazolam for 2 weeks or longer.
You may have more difficulty falling asleep or staying asleep on the first few nights after you stop taking triazolam than you did before you started taking the medication. This is normal and usually gets better without treatment after one or two nights.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with triazolam and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking triazolam,
-
tell your doctor and pharmacist if you are allergic to triazolam; other benzodiazepines; any other medications; or any of the ingredients in triazolam tablets. Ask your pharmacist for a list of the ingredients.
-
tell your doctor if you are taking any of the following medications: antifungal medications including itraconazole (Onmel, Sporanox) and ketoconazole (Nizoral); certain medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) including indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); and nefazodone. Your doctor will probably tell you not to take triazolam.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Nexterone, Pacerone); certain antibiotics such as clarithromycin (Biaxin, in Prevpac), erythromycin (Erythrocin, E-mycin), telithromycin (Ketek), and troleandomycin (TAO) (not available in the US); antidepressants; certain antifungal medications; antihistamines; certain calcium channel blockers such as diltiazem (Cardizem, Dilacor, Tiazac, others), nicardipine (Cardene), nifedipine (Adalat, Afeditab, Procardia), and verapamil (Calan, Verelan); cyclosporine (Gengraf, Neoral, Sandimmune); ergotamine (Cafergot, Ergomar, Migranal, others); certain histamine-2 receptor blockers (H2 blockers) such as cimetidine (Tagamet) and ranitidine (Zantac); hormonal contraceptives (birth control pills, patches, rings, implants, or injections); isoniazid (Laniazid, in Rifamate, in Rifater); medications for anxiety, colds or allergies, mental illness, or seizures; muscle relaxants; sedatives; certain selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); other sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with triazolam, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.
-
tell your doctor if you have ever thought about killing yourself or tried to do so, and if you have or have ever had any condition that affects your breathing, sleep apnea (condition in which a person briefly stops breathing many times during the night), seizures, or kidney or liver disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking triazolam, call your doctor immediately. Triazolam may harm the fetus.
-
talk to your doctor about the safe use of triazolam if you are 65 years of age or older. Older adults should usually take lower doses of triazolam because higher doses may not be more effective and are more likely to cause serious side effects.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking triazolam.
-
you should know that triazolam may make you drowsy during the daytime, may decrease your mental alertness, and may increase the risk that you could fall. Take extra care to be sure you do not fall, especially if you get out of bed in the middle of the night. Do not drive a car or operate machinery until you know how this medication affects you.
-
you should know that some people who took medications for sleep got out of bed and drove their cars, prepared and ate food, had sex, made phone calls, or were involved in other activities while partially asleep. After they woke up, these people were usually unable to remember what they had done. Call your doctor right away if you find out that you have been driving or doing anything else while you were sleeping.
-
you should know that your mental health may change in unexpected ways while you are taking this medication. It is hard to tell if these changes are caused by triazolam or if they are caused by physical or mental illnesses that you already have or suddenly develop. Tell your doctor right away if you experience any of the following symptoms: aggressiveness, strange or unusually outgoing behavior, hallucinations (seeing things or hearing voices that do not exist), feeling as if you are outside of your body, memory problems, difficulty concentrating, slowed speech or movements, new or worsening depression, thinking about killing yourself, confusion, and any other changes in your usual thoughts, mood, or behavior. Be sure that your family knows which symptoms may be serious so that they can call the doctor if you are unable to seek treatment on your own.
What special dietary instructions should I follow?
Do not eat grapefruit or drink grapefruit juice while taking this medication.
What should I do if I forget a dose?
Triazolam should only be taken at bedtime. If you did not take triazolam at bedtime and you are unable to fall asleep, you may take triazolam if you will be able to remain in bed for 7 to 8 hours afterward. Do not take triazolam if you are not ready to go to sleep right away and stay asleep for at least 7 to 8 hours.
What side effects can this medication cause?
-
Triazolam may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
drowsiness
-
dizziness
-
lightheadedness
-
headache
-
problems with coordination
-
nervousness
-
tingling of the skin
-
nausea
-
vomiting
-
-
Some side effects can be serious. If you experience any of these symptoms or those listed in the SPECIAL PRECAUTIONS or IMPORTANT WARNING sections, call your doctor immediately or get emergency medical help:
-
rash
-
hives
-
itching
-
swelling of the eyes, face, lips, tongue, or throat
-
feeling that the throat is closing
-
difficulty breathing or swallowing
-
hoarseness
-
-
Triazolam may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Keep triazolam in a safe place so that no one else can take it accidentally or on purpose. Keep track of how many capsules are left so you will know if any are missing.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
extreme drowsiness
-
confusion
-
problems with coordination
-
slurred speech
-
slow or difficult breathing
-
seizures
-
coma (loss of consciousness for a period of time)
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to triazolam.
Do not let anyone else take your medication. Triazolam is a controlled substance. Prescriptions may be refilled only a limited number of times; ask your pharmacist if you have any questions.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Montelukast | Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Triazolam. |
Leflunomide | Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Leflunomide. |
Delavirdine | Delavirdine The metabolism of Triazolam can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Triazolam can be decreased when combined with Nevirapine. |
Atorvastatin | Atorvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Atorvastatin. |
Dolasetron | Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Triazolam. |
Alendronate | Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Triazolam. |
Aminophylline | Aminophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Aminophylline. |
Cilostazol | Cilostazol Triazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clopidogrel | Clopidogrel The metabolism of Triazolam can be decreased when combined with Clopidogrel. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Triazolam. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The serum concentration of Triazolam can be increased when it is combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Fenofibrate | Fenofibrate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fenofibrate. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Triazolam is combined with Guanfacine. |
Magnesium Hydroxide | Magnesium Hydroxide Triazolam may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Mycophenolate | Mycophenolate Triazolam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Nafarelin | Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Triazolam. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Naratriptan. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Triazolam. |
Potassium | Potassium Potassium may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Prednisone may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ranitidine | Ranitidine The serum concentration of Triazolam can be increased when it is combined with Ranitidine. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Triazolam. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Rizatriptan. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Triazolam. |
Tacrolimus | Tacrolimus The metabolism of Triazolam can be decreased when combined with Tacrolimus. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Triazolam. |
Triamcinolone | Triamcinolone The metabolism of Triazolam can be increased when combined with Triamcinolone. |
Zolmitriptan | Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triazolam. |
Ampicillin Injection | Ampicillin Injection Ampicillin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection The metabolism of Triazolam can be decreased when combined with Fluconazole. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam. |
Levofloxacin Injection | Levofloxacin Injection Triazolam may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Triazolam. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of sedation can be increased when Triazolam is combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Triazolam. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Triazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Triazolam. |
Altretamine | Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Triazolam can be decreased when combined with Cyclosporine. |
Ondansetron | Ondansetron The risk or severity of adverse effects can be increased when Triazolam is combined with Ondansetron. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Triazolam. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Triazolam. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Triazolam is combined with Alosetron. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Triazolam. |
Eprosartan | Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Triazolam. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Oxcarbazepine | Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Triazolam. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Risedronate | Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Triazolam. |
Temozolomide | Temozolomide Temozolomide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Zaleplon | Zaleplon The risk or severity of adverse effects can be increased when Triazolam is combined with Zaleplon. |
Anakinra | Anakinra The metabolism of Triazolam can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Triazolam is combined with Desloratadine. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Triazolam. |
Trimipramine | Trimipramine The risk or severity of adverse effects can be increased when Trimipramine is combined with Triazolam. |
Etanercept Injection | Etanercept Injection The metabolism of Triazolam can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Modafinil | Modafinil The metabolism of Triazolam can be increased when combined with Modafinil. |
Perindopril | Perindopril Perindopril may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Sirolimus | Sirolimus The serum concentration of Triazolam can be increased when it is combined with Sirolimus. |
Dutasteride | Dutasteride The metabolism of Dutasteride can be decreased when combined with Triazolam. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Escitalopram. |
Zonisamide | Zonisamide Triazolam may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy. |
Adalimumab Injection | Adalimumab Injection The metabolism of Triazolam can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Aripiprazole. |
Atomoxetine | Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Triazolam. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Triazolam is combined with Dexmethylphenidate. |
Atazanavir | Atazanavir Atazanavir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Almotriptan | Almotriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Almotriptan. |
Eletriptan | Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Triazolam. |
Mefloquine | Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Triazolam. |
Rosuvastatin | Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Rosuvastatin. |
Vardenafil | Vardenafil The metabolism of Triazolam can be decreased when combined with Vardenafil. |
Aprepitant | Aprepitant The metabolism of Triazolam can be decreased when combined with Aprepitant. |
Emtricitabine | Emtricitabine Emtricitabine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Memantine | Memantine Triazolam may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tadalafil | Tadalafil Tadalafil may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Frovatriptan. |
Progesterone | Progesterone The metabolism of Triazolam can be decreased when combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Triazolam. |
Infliximab Injection | Infliximab Injection The metabolism of Triazolam can be increased when combined with Infliximab. |
Protriptyline | Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Triazolam. |
Duloxetine | Duloxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Triazolam can be decreased when combined with Norethisterone. |
Tinidazole | Tinidazole Triazolam may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Trospium | Trospium Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Cefditoren | Cefditoren Cefdinir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Triazolam can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Triazolam is combined with Eszopiclone. |
Ganciclovir | Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ganciclovir. |
Ribavirin | Ribavirin Ribavirin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Solifenacin | Solifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Solifenacin. |
Valganciclovir | Valganciclovir Triazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The metabolism of Triazolam can be decreased when combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam. |
Sodium Oxybate | Sodium Oxybate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
Ibandronate | Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Triazolam. |
Isocarboxazid | Isocarboxazid The risk or severity of adverse effects can be increased when Triazolam is combined with Isocarboxazid. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Ramelteon. |
Darifenacin | Darifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Darifenacin. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Triazolam. |
Pregabalin | Pregabalin The therapeutic efficacy of Triazolam can be increased when used in combination with Pregabalin. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be decreased when Triazolam is combined with Phenylephrine. |
Felbamate | Felbamate The risk or severity of adverse effects can be increased when Triazolam is combined with Felbamate. |
Ranolazine | Ranolazine Ranolazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Abatacept Injection | Abatacept Injection The metabolism of Triazolam can be increased when combined with Abatacept. |
Rasagiline | Rasagiline The risk or severity of adverse effects can be increased when Triazolam is combined with Rasagiline. |
Imatinib | Imatinib The metabolism of Triazolam can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin Triazolam may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Triazolam may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Gefitinib | Gefitinib The metabolism of Triazolam can be decreased when combined with Gefitinib. |
Albuterol | Albuterol Triazolam may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Paliperidone. |
Clofarabine Injection | Clofarabine Injection Clofarabine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Lubiprostone | Lubiprostone Triazolam may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Pemetrexed Injection | Pemetrexed Injection Triazolam may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Triazolam is combined with Dimenhydrinate. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Sorafenib | Sorafenib The metabolism of Triazolam can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Sunitinib can be decreased when combined with Triazolam. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Lapatinib | Lapatinib The metabolism of Lapatinib can be decreased when combined with Triazolam. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Triazolam is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Triazolam may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The metabolism of Dasatinib can be decreased when combined with Triazolam. |
Armodafinil | Armodafinil The metabolism of Triazolam can be increased when combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection Triazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ivermectin | Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Triazolam. |
Temsirolimus | Temsirolimus The serum concentration of Triazolam can be increased when it is combined with Temsirolimus. |
Lenalidomide | Lenalidomide Lenalidomide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Raltegravir | Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Raltegravir. |
Budesonide | Budesonide The metabolism of Triazolam can be increased when combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Triazolam can be decreased when combined with Chloramphenicol. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam. |
Doripenem Injection | Doripenem Injection Triazolam may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Triazolam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Triazolam is combined with Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tretinoin | Tretinoin The metabolism of Triazolam can be decreased when combined with Tretinoin. |
Certolizumab Injection | Certolizumab Injection The metabolism of Triazolam can be increased when combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The serum concentration of Triazolam can be increased when it is combined with Ixabepilone. |
Irinotecan Injection | Irinotecan Injection The metabolism of Triazolam can be decreased when combined with Irinotecan. |
Daptomycin Injection | Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Triazolam. |
Praziquantel | Praziquantel The metabolism of Praziquantel can be decreased when combined with Triazolam. |
Methylnaltrexone Injection | Methylnaltrexone Injection Triazolam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Triazolam. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Triazolam. |
Naltrexone Injection | Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Triazolam. |
Dexrazoxane Injection | Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Triazolam may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Iloperidone. |
Prasugrel | Prasugrel Triazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide The risk or severity of adverse effects can be increased when Triazolam is combined with Lacosamide. |
Everolimus | Everolimus The serum concentration of Triazolam can be increased when it is combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Triazolam can be decreased when combined with Dronedarone. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam. |
Pralatrexate Injection | Pralatrexate Injection Triazolam may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Triazolam. |
Saxagliptin | Saxagliptin Triazolam may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Triazolam may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Romidepsin Injection | Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Triazolam. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Topotecan | Topotecan Triazolam may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Golimumab Injection | Golimumab Injection The metabolism of Triazolam can be increased when combined with Golimumab. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Triazolam is combined with Asenapine. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Triazolam is combined with Vigabatrin. |
Pitavastatin | Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Pitavastatin. |
Levonorgestrel | Levonorgestrel The metabolism of Triazolam can be decreased when combined with Levonorgestrel. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Triazolam. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Triazolam can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Triazolam may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Triazolam. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Triazolam is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection Acetaminophen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Vilazodone | Vilazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Triazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Terbutaline Injection | Terbutaline Injection Terbutaline may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Roflumilast | Roflumilast Triazolam may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Triazolam can be decreased when combined with Cyclophosphamide. |
Rivaroxaban | Rivaroxaban Triazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ruxolitinib | Ruxolitinib Triazolam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Clobazam | Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Triazolam. |
Ivacaftor | Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Triazolam. |
Deferiprone | Deferiprone Triazolam may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Triazolam. |
Crizotinib | Crizotinib The metabolism of Triazolam can be decreased when combined with Crizotinib. |
Cabergoline | Cabergoline The risk or severity of adverse effects can be increased when Cabergoline is combined with Triazolam. |
Naloxone Injection | Naloxone Injection Triazolam may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Ambrisentan | Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Triazolam. |
Fondaparinux Injection | Fondaparinux Injection Fondaparinux may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Triazolam is combined with Tiagabine. |
Iloprost | Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Iloprost. |
Enzalutamide | Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Triazolam. |
Mirabegron | Mirabegron Triazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Teduglutide Injection | Teduglutide Injection The serum concentration of Triazolam can be increased when it is combined with Teduglutide. |
Alogliptin | Alogliptin Triazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Triazolam. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Triazolam is combined with Pomalidomide. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Triazolam. |
Apixaban | Apixaban The metabolism of Apixaban can be decreased when combined with Triazolam. |
Canagliflozin | Canagliflozin Canagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Trametinib | Trametinib Triazolam may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Ertapenem may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Vortioxetine | Vortioxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Vortioxetine. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Triazolam. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Simeprevir | Simeprevir The serum concentration of Triazolam can be increased when it is combined with Simeprevir. |
Sofosbuvir | Sofosbuvir Triazolam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Dapagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast The metabolism of Triazolam can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Triazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Siltuximab Injection | Siltuximab Injection The metabolism of Triazolam can be increased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Triazolam is combined with Eslicarbazepine. |
Testosterone Injection | Testosterone Injection The metabolism of Triazolam can be decreased when combined with Testosterone. |
Hydrocodone | Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Suvorexant | Suvorexant Triazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Edoxaban | Edoxaban Triazolam may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Olaparib | Olaparib The metabolism of Olaparib can be decreased when combined with Triazolam. |
Methamphetamine | Methamphetamine The risk or severity of adverse effects can be increased when Triazolam is combined with Metamfetamine. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Tasimelteon. |
Secukinumab Injection | Secukinumab Injection The metabolism of Triazolam can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Triazolam. |
Haloperidol Injection | Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Triazolam. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Triazolam may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Flibanserin. |
Daclatasvir | Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Triazolam. |
Brexpiprazole | Brexpiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Triazolam. |
Cariprazine | Cariprazine The risk or severity of adverse effects can be increased when Triazolam is combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Triazolam may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of adverse effects can be increased when Eluxadoline is combined with Triazolam. |
Trabectedin Injection | Trabectedin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Trabectedin. |
Ixazomib | Ixazomib Triazolam may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Triazolam may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Triazolam can be increased when combined with Dexamethasone. |
Brivaracetam Injection | Brivaracetam Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brivaracetam. |
Cobicistat | Cobicistat The metabolism of Triazolam can be decreased when combined with Cobicistat. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Furosemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The metabolism of Triazolam can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Triazolam may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Doxepin (Insomnia) | Doxepin (Insomnia) Triazolam may increase the central nervous system depressant (CNS depressant) activities of Doxepin. |
Deutetrabenazine | Deutetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Deutetrabenazine. |
Valbenazine | Valbenazine Triazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The metabolism of Triazolam can be increased when combined with Deflazacort. |
Safinamide | Safinamide The metabolism of Triazolam can be decreased when combined with Safinamide. |
Naldemedine | Naldemedine Triazolam may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Midostaurin | Midostaurin The metabolism of Triazolam can be increased when combined with Midostaurin. |
Benznidazole | Benznidazole Triazolam may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Triazolam. |
Delafloxacin | Delafloxacin Triazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Acalabrutinib | Acalabrutinib The metabolism of Triazolam can be decreased when combined with Acalabrutinib. |
Letermovir | Letermovir The metabolism of Triazolam can be decreased when combined with Letermovir. |
Tetrabenazine | Tetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection Triazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide Triazolam may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Penicillamine | Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Triazolam. |
Baricitinib | Baricitinib Triazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Triazolam can be increased when used in combination with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Triazolam may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Doravirine | Doravirine The metabolism of Doravirine can be decreased when combined with Triazolam. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triazolam. |
Stiripentol | Stiripentol The risk or severity of adverse effects can be increased when Triazolam is combined with Stiripentol. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Triazolam. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Triazolam. |
Prucalopride | Prucalopride Triazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Triazolam can be increased when combined with Emapalumab. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brexanolone. |
Cladribine | Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Triazolam. |
Solriamfetol | Solriamfetol The risk or severity of adverse effects can be increased when Triazolam is combined with Solriamfetol. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Triazolam. |
Pitolisant | Pitolisant The serum concentration of Triazolam can be decreased when it is combined with Pitolisant. |
Phenytoin Injection | Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Triazolam. |
Fosphenytoin Injection | Fosphenytoin Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Fosphenytoin. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Triazolam is combined with Lumateperone. |
Lasmiditan | Lasmiditan The risk or severity of adverse effects can be increased when Triazolam is combined with Lasmiditan. |
Cenobamate | Cenobamate The serum concentration of Triazolam can be decreased when it is combined with Cenobamate. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Triazolam. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Triazolam. |
Lemborexant | Lemborexant The risk or severity of adverse effects can be increased when Triazolam is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Triazolam. |
Pralsetinib | Pralsetinib The metabolism of Triazolam can be decreased when combined with Pralsetinib. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Triazolam can be decreased when it is combined with Satralizumab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Triazolam is combined with Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Theophylline | Theophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Theophylline. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Trazodone | Trazodone The risk or severity of adverse effects can be increased when Trazodone is combined with Triazolam. |
Isotretinoin | Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isotretinoin. |
Sucralfate | Sucralfate Sucralfate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Floxuridine | Floxuridine Floxuridine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Phenobarbital | Phenobarbital The risk or severity of adverse effects can be increased when Triazolam is combined with Phenobarbital. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Triazolam. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Triazolam. |
Primidone | Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Triazolam. |
Methsuximide | Methsuximide The risk or severity of adverse effects can be increased when Triazolam is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Triazolam is combined with Diethylpropion. |
Chlorpromazine | Chlorpromazine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Triazolam. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Triazolam. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Triazolam. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Triazolam. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Triazolam. |
Carmustine | Carmustine Carmustine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Amantadine | Amantadine Triazolam may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Triazolam. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Triazolam. |
Bromocriptine | Bromocriptine The risk or severity of adverse effects can be increased when Triazolam is combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Triazolam. |
Phenelzine | Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Triazolam. |
Procarbazine | Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Procarbazine. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of adverse effects can be increased when Triazolam is combined with Ergoloid mesylate. |
Tetracycline | Tetracycline Tetracycline may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Triazolam. |
Thioridazine | Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Triazolam. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triazolam. |
Bleomycin | Bleomycin Bleomycin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dapsone | Dapsone The metabolism of Triazolam can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine Sulfadiazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Triazolam. |
Methadone | Methadone Triazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
Oxybutynin | Oxybutynin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin. |
Benztropine | Benztropine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Maprotiline | Maprotiline The risk or severity of adverse effects can be increased when Triazolam is combined with Maprotiline. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Triazolam. |
Azathioprine | Azathioprine Triazolam may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triazolam. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Amoxapine | Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Triazolam. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Hydrocortisone | Hydrocortisone The metabolism of Triazolam can be decreased when combined with Hydrocortisone. |
Cytarabine | Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Cytarabine. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Carbamazepine | Carbamazepine The metabolism of Triazolam can be decreased when combined with Carbamazepine. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Triazolam is combined with Molindone. |
Methyldopa | Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Methyldopa. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Triazolam. |
Hydralazine | Hydralazine Triazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine The metabolism of Triazolam can be decreased when combined with Cimetidine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Warfarin | Warfarin Warfarin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Triazolam is combined with Clonazepam. |
Promethazine | Promethazine The risk or severity of adverse effects can be increased when Triazolam is combined with Promethazine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Daunorubicin | Daunorubicin The metabolism of Triazolam can be increased when combined with Daunorubicin. |
Nitrofurantoin | Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Digoxin | Digoxin Triazolam may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Triazolam. |
Chloroquine | Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Triazolam. |
Quinine | Quinine The risk or severity of adverse effects can be increased when Quinine is combined with Triazolam. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Triazolam. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Metolazone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Clindamycin Injection | Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Triazolam. |
Secobarbital | Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Triazolam. |
Desipramine | Desipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Desipramine. |
Amitriptyline | Amitriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline. |
Imipramine | Imipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Imipramine. |
Probenecid | Probenecid Triazolam may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine The metabolism of Triazolam can be decreased when combined with Quinidine. |
Procainamide | Procainamide Triazolam may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Pyrazinamide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Rifampin | Rifampin The metabolism of Triazolam can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Disopyramide. |
Valproic Acid | Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Triazolam. |
Tamoxifen | Tamoxifen The metabolism of Triazolam can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Triazolam. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Methimazole | Methimazole Methimazole may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Propylthiouracil | Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Triazolam. |
Chlorpropamide | Chlorpropamide Chlorpropamide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tolbutamide | Tolbutamide Triazolam may decrease the excretion rate of Tolbutamide which could result in a higher serum level. |
Tolazamide | Tolazamide Tolazamide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Triazolam. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Triazolam is combined with Cyclobenzaprine. |
Niacin | Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Triazolam. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Triazolam. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Cyproheptadine | Cyproheptadine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine. |
Clemastine | Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Triazolam. |
Chlorpheniramine | Chlorpheniramine The risk or severity of adverse effects can be increased when Triazolam is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Triazolam. |
Meclizine | Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Triazolam. |
Ethambutol | Ethambutol Ethambutol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Triazolam is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Triazolam. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Triazolam. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Triazolam. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Disulfiram | Disulfiram The metabolism of Triazolam can be decreased when combined with Disulfiram. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Nortriptyline | Nortriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Mercaptopurine | Mercaptopurine The therapeutic efficacy of Triazolam can be decreased when used in combination with Mercaptopurine. |
Phytonadione | Phytonadione Triazolam may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Nadolol | Nadolol Triazolam may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Triazolam. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triazolam. |
Allopurinol | Allopurinol Allopurinol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Triazolam. |
Flavoxate | Flavoxate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Flavoxate. |
Colchicine | Colchicine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Colchicine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dacarbazine | Dacarbazine Dacarbazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Triazolam. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ketoconazole | Ketoconazole The metabolism of Triazolam can be decreased when combined with Ketoconazole. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Triazolam is combined with Pyrantel. |
Vincristine Injection | Vincristine Injection The metabolism of Triazolam can be decreased when combined with Vincristine. |
Captopril | Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Captopril. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Metoprolol | Metoprolol Metoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Hydroxyzine | Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Triazolam is combined with Thiothixene. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Triazolam. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Triazolam. |
Dicyclomine | Dicyclomine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine. |
Hyoscyamine | Hyoscyamine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Propantheline. |
Trimethoprim | Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Triazolam. |
Diltiazem | Diltiazem The metabolism of Triazolam can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Nifedipine can be decreased when combined with Triazolam. |
Timolol | Timolol Timolol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Verapamil | Verapamil The metabolism of Triazolam can be decreased when combined with Verapamil. |
Pindolol | Pindolol The risk or severity of adverse effects can be increased when Triazolam is combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection Triazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Bumetanide | Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Triazolam. |
Etoposide | Etoposide The metabolism of Triazolam can be decreased when combined with Etoposide. |
Glyburide | Glyburide The metabolism of Glyburide can be decreased when combined with Triazolam. |
Glipizide | Glipizide Triazolam may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Indapamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Triazolam may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Oxacillin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Pentoxifylline. |
Pentamidine Injection | Pentamidine Injection Pentamidine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Labetalol | Labetalol Labetalol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Auranofin | Auranofin Triazolam may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam. |
Gemfibrozil | Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Gemfibrozil. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Triazolam. |
Enalapril | Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Triazolam. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Amiodarone | Amiodarone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Aztreonam may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Buspirone | Buspirone Buspirone may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Lovastatin | Lovastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Triazolam. |
Ciprofloxacin | Ciprofloxacin The metabolism of Triazolam can be decreased when combined with Ciprofloxacin. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Fluoxetine | Fluoxetine The serum concentration of Triazolam can be increased when it is combined with Fluoxetine. |
Clozapine | Clozapine The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Estazolam. |
Ofloxacin | Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ofloxacin. |
Didanosine | Didanosine Triazolam may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Pentostatin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Clarithromycin | Clarithromycin The serum concentration of Triazolam can be increased when it is combined with Clarithromycin. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Felodipine | Felodipine The metabolism of Felodipine can be decreased when combined with Triazolam. |
Fosinopril | Fosinopril Fosinopril may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Pravastatin | Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Triazolam. |
Simvastatin | Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Triazolam. |
Teniposide Injection | Teniposide Injection The metabolism of Triazolam can be decreased when combined with Teniposide. |
Itraconazole | Itraconazole The metabolism of Triazolam can be decreased when combined with Itraconazole. |
Lisinopril | Lisinopril Lisinopril may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Bisoprolol | Bisoprolol Bisoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Zolpidem | Zolpidem Triazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Isradipine | Isradipine Isradipine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cisapride | Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Triazolam. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Triazolam is combined with Gabapentin. |
Fluvastatin | Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fluvastatin. |
Venlafaxine | Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triazolam. |
Nizatidine | Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Triazolam. |
Stavudine | Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Triazolam. |
Fluvoxamine | Fluvoxamine The risk or severity of adverse effects can be increased when Triazolam is combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Nefazodone. |
Lamotrigine | Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Triazolam. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of CNS depression can be increased when Tramadol is combined with Triazolam. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Triazolam. |
Nicardipine | Nicardipine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nicardipine. |
Bupropion | Bupropion The risk or severity of adverse effects can be increased when Triazolam is combined with Bupropion. |
Ticlopidine | Ticlopidine Ticlopidine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Saquinavir | Saquinavir The serum concentration of Triazolam can be increased when it is combined with Saquinavir. |
Metformin | Metformin Metformin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Nisoldipine | Nisoldipine Nisoldipine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Lamivudine | Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Triazolam. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Triazolam. |
Acarbose | Acarbose Acarbose may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection Gemcitabine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Indinavir | Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Triazolam. |
Ritonavir | Ritonavir The serum concentration of Triazolam can be increased when it is combined with Ritonavir. |
Docetaxel Injection | Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Triazolam. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Meropenem may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Clomipramine | Clomipramine The risk or severity of adverse effects can be increased when Triazolam is combined with Clomipramine. |
Fosfomycin | Fosfomycin Fosfomycin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Mirtazapine | Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Triazolam. |
Pramipexole | Pramipexole Triazolam may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Triazolam. |
Nelfinavir | Nelfinavir The metabolism of Triazolam can be decreased when combined with Nelfinavir. |
Nilutamide | Nilutamide Nilutamide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Flutamide | Flutamide Flutamide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Selegiline | Selegiline The risk or severity of adverse effects can be increased when Triazolam is combined with Selegiline. |
Sertraline | Sertraline The risk or severity of adverse effects can be increased when Triazolam is combined with Sertraline. |
Letrozole | Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Letrozole. |
Tamsulosin | Tamsulosin Tamsulosin may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Ropinirole | Ropinirole Triazolam may increase the sedative activities of Ropinirole. |
Finasteride | Finasteride The metabolism of Finasteride can be decreased when combined with Triazolam. |
Quetiapine | Quetiapine The risk or severity of adverse effects can be increased when Triazolam is combined with Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Triazolam. |
Paroxetine | Paroxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Paroxetine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Triazolam. |
Citalopram | Citalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Citalopram. |
Capecitabine | Capecitabine Triazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Efavirenz | Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Triazolam. |
Abacavir | Abacavir Triazolam may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Sildenafil | Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Triazolam. |
Celecoxib | Celecoxib Celecoxib may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Rosiglitazone | Rosiglitazone Rosiglitazone may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Tolterodine | Tolterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Tolterodine. |
Thalidomide | Thalidomide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Nateglinide | Nateglinide Nateglinide may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Triazolam. |
Rabeprazole | Rabeprazole Triazolam may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Terbinafine | Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Triazolam. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists